Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Gerard Bruin

3PUBLICATIONS

5CO-AUTHORS

Pharmaceutical delivery technologies

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jun 02, 2025

Model-Informed Drug Development-Based Bridging from Subcutaneous to Intravenous Secukinumab Dosing: Approval in Psoriatic Arthritis and Axial Spondyloarthritis.

Thomas Dumortier, Guillermo Valenzuela, Melvin Churchill

|Dec 26, 2021

Secukinumab demonstrates efficacy, safety, and tolerability upon administration by 2 ml autoinjector in adult patients with plaque psoriasis: 52-week results from MATURE, a randomized, placebo-controlled trial.

Bardur Sigurgeirsson, John Browning, Stephen Tyring

|Oct 29, 2019

Comparison of pharmacokinetics, safety and tolerability of secukinumab administered subcutaneously using different delivery systems in healthy volunteers and in psoriasis patients.

Gerard Bruin, Hans-Ulrich P Hockey, Phillip La Stella

Pageof 1

Frequent Collaborators

2 joint publications

Bárdur Sigurgeirsson

1 joint publications

Jacek C Szepietowski

1 joint publications

Raquel Rivera-Díaz

1 joint publications

Thomas Dumortier

1 joint publications

Didier Renard

Frequent Collaborators

2 joint publications

Bárdur Sigurgeirsson

1 joint publications

Jacek C Szepietowski

1 joint publications

Raquel Rivera-Díaz

1 joint publications

Thomas Dumortier

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on : Jan 27, 2018

Measuring Psoriasis Severity at Home

Measuring Psoriasis Severity at Home

Published on : Mar 01, 2024

See more related videos

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on : Jan 27, 2018

Measuring Psoriasis Severity at Home

Measuring Psoriasis Severity at Home

Published on : Mar 01, 2024

See more related videos